Furthermore, the IHC assay of the subcutaneous xenograft also revealed that LRRC1 could promote the expression levels of angiogenesis factors VEGFA and CD31, providing novel evidence that LRRC1 has a regulatory function in HCC angiogenesis in vitro and in vivo. The gene discussed is PECAM1; the disease is hepatocellular carcinoma.